Targeting Candida albicans filamentation for antifungal drug development.
about
Bridging the Gap to Non-toxic Fungal Control: Lupinus-Derived Blad-Containing Oligomer as a Novel Candidate to Combat Human Pathogenic Fungi.Screening the Pathogen Box for Identification of Candida albicans Biofilm InhibitorsGenome-wide functional analysis in Candida albicans.Antimicrobial Compounds Produced by Vaginal Lactobacillus crispatus Are Able to Strongly Inhibit Candida albicans Growth, Hyphal Formation and Regulate Virulence-related Gene Expressions.Future therapies targeted towards eliminating Candida biofilms and associated infections.Chemical inhibitors of Candida albicans hyphal morphogenesis target endocytosis.Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation.Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds.Clinical strains of Lactobacillus reduce the filamentation of Candida albicans and protect Galleria mellonella against experimental candidiasis.Fungicidal PMMA-Undecylenic Acid Composites.The unmet clinical need of novel antifungal drugs.Hexosomes with Undecylenic Acid Efficient against Candida albicans.Biogenic nanosilver synthesized in Metarhizium robertsii waste mycelium extract - As a modulator of Candida albicans morphogenesis, membrane lipidome and biofilm.Promising Antifungal Targets Against Based on Ion HomeostasisAn insight into new strategies to combat antifungal drug resistance
P2860
Q33843321-BA58CC96-1D90-4335-A8C6-48BA8FAE7961Q36177985-CE03F7F2-7583-49D2-AFD0-23740F45ADB1Q36302129-84920D93-B529-49BB-AA96-E9102B81B74CQ37736301-7895D40C-B3D3-4AEB-9880-CB1451CB0109Q38786061-3AC2FAE5-34DE-48E4-B647-80437E0E4EEAQ40129265-7513ED55-54A4-4A51-A407-189B6105DE81Q47189974-0B40D219-ED32-4DF3-BF0C-5EA7B8577F74Q48163141-EBDE1710-E2BF-4FA6-B6C1-ACB67E135766Q48243552-C54B3AE1-5AE0-4DEA-A84B-0B8523CE451DQ48278197-41AC5F88-2F9F-4D7E-A148-D31D3F145149Q50068450-5826D471-2CA8-432B-989E-900CE7E08B84Q50133813-52713E1F-FCD0-4A19-A260-37BFF0816F9AQ52648791-8146548F-438D-4B83-A598-88FAB8A1EA97Q57161198-55B27199-7C0C-4821-97DB-25076C129BD3Q59135042-38ABBB6B-EF5C-47DE-A8CE-49D92F4D4640
P2860
Targeting Candida albicans filamentation for antifungal drug development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting Candida albicans filamentation for antifungal drug development.
@en
Targeting Candida albicans filamentation for antifungal drug development.
@nl
type
label
Targeting Candida albicans filamentation for antifungal drug development.
@en
Targeting Candida albicans filamentation for antifungal drug development.
@nl
prefLabel
Targeting Candida albicans filamentation for antifungal drug development.
@en
Targeting Candida albicans filamentation for antifungal drug development.
@nl
P2093
P2860
P1433
P1476
Targeting Candida albicans filamentation for antifungal drug development
@en
P2093
Christopher G Pierce
José L Lopez-Ribot
Stanton F McHardy
Stephen P Saville
Taissa Vila
P2860
P304
P356
10.1080/21505594.2016.1197444
P50
P577
2016-06-07T00:00:00Z